MedPath

Explorative trial of suppression effect of preoperative enteral nutrition enrichied with Eicosapentaenoic Acid(EPA) for hypercytokinemia after pancreaticoduodenectomy :a double blinded and randomaized controlled trial

Not Applicable
Recruiting
Conditions
Patients to require pancreaticoduodenectomy
Registration Number
JPRN-UMIN000007533
Lead Sponsor
Shizuoka Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

(1)With poor oral intake (2)With other nutrition therapy (3)Being immunocompromised status or receiving steroids (4)With uncontrolled diabetes mellitus (5)With inflammatory bowel disease (6)With bacterial or viral infection (7)With radiation therapy, chemotherapy or nutrition therapy before registration (8)With psychiatric disorder (9)Possibly pregnant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath